Supplemental Subsidiary Guarantors (Details) (USD $) | 3 Months Ended | | |
In Thousands, unless otherwise specified | Jan. 31, 2014 | Jan. 25, 2013 | Oct. 25, 2013 | Oct. 26, 2012 |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | $839,312 | $1,149,877 | ' | ' |
Cost of sales | 604,178 | 773,149 | ' | ' |
Product development, selling and administrative expenses | 153,029 | 157,281 | ' | ' |
Other (income) expense, net | -3,140 | -1,705 | ' | ' |
Operating income | 85,245 | 221,152 | ' | ' |
Income from continuing operations before income taxes | 71,425 | 205,999 | ' | ' |
Provision for income taxes | 22,564 | 63,860 | ' | ' |
Income from continuing operations | 48,861 | 142,139 | ' | ' |
Comprehensive income | 2,403 | 145,367 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 290,899 | 269,895 | ' | ' |
Accounts receivable, net | 953,792 | ' | 1,083,663 | ' |
Inventories | 1,135,112 | ' | 1,139,744 | ' |
Other current assets | 208,031 | ' | 193,328 | ' |
Total current assets | 2,587,834 | ' | 2,822,444 | ' |
Property, plant and equipment, net | 897,884 | ' | 912,642 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 325,572 | ' | 331,812 | ' |
Goodwill | 1,479,321 | ' | 1,480,519 | ' |
Deferred income taxes | 37,723 | ' | 41,532 | ' |
Other non-current assets | 195,342 | ' | 200,633 | ' |
Total other assets | 2,037,958 | ' | 2,054,496 | ' |
Total assets | 5,523,676 | 6,176,798 | 5,789,582 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 58,356 | ' | 58,669 | ' |
Trade accounts payable | 283,969 | ' | 388,119 | ' |
Employee compensation and benefits | 95,766 | ' | 130,555 | ' |
Advance payments and progress billings | 472,846 | ' | 399,768 | ' |
Accrued warranties | 77,804 | 87,427 | 85,732 | 100,646 |
Other accrued liabilities | 243,088 | ' | 286,063 | ' |
Current liabilities of discontinued operations | 11,684 | ' | 11,684 | ' |
Total current liabilities | 1,243,513 | ' | 1,360,590 | ' |
Long-term obligations | 1,243,874 | ' | 1,256,927 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 20,319 | ' | 20,723 | ' |
Accrued pension costs | 144,321 | ' | 149,805 | ' |
Other non-current liabilities | 146,610 | ' | 143,168 | ' |
Total other liabilities | 311,250 | ' | 313,696 | ' |
Shareholders’ equity | 2,725,039 | ' | 2,858,369 | ' |
Total liabilities and shareholders’ equity | 5,523,676 | ' | 5,789,582 | ' |
Operating Activities: | ' | ' | ' | ' |
Net cash provided (used) by operating activities of continuing operations | 64,839 | 92,065 | ' | ' |
Net cash provided (used) by operating activities of discontinued operations | 67 | -1,571 | ' | ' |
Net cash provided by operating activities | 64,906 | 90,494 | ' | ' |
Investing Activities: | ' | ' | ' | ' |
Property, plant and equipment acquired | -26,655 | -54,588 | ' | ' |
Proceeds from sale of property, plant and equipment | 2,081 | 1,053 | ' | ' |
Other investing activities, net | -21 | 1,793 | ' | ' |
Net cash used by investing activities | -24,595 | -51,742 | ' | ' |
Financing Activities: | ' | ' | ' | ' |
Common stock issued | 1,985 | 3,012 | ' | ' |
Excess tax (detriment) benefit from share-based compensation awards | -284 | 1,522 | ' | ' |
Dividends paid | -17,850 | -18,542 | ' | ' |
Repayments of term loan | -12,500 | -12,500 | ' | ' |
Change in short and other long-term obligations, net | -1,259 | -4,702 | ' | ' |
Treasury stock purchased | -122,036 | 0 | ' | ' |
Net cash used by financing activities | -151,944 | -31,210 | ' | ' |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -3,177 | -1,520 | ' | ' |
(Decrease) Increase in Cash and Cash Equivalents | -114,810 | 6,022 | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 405,709 | 263,873 | ' | ' |
Cash and Cash Equivalents at End of Period | 290,899 | 269,895 | ' | ' |
Parent Company | ' | ' | ' | ' |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | 0 | 0 | ' | ' |
Cost of sales | 0 | 0 | ' | ' |
Product development, selling and administrative expenses | 14,669 | 12,802 | ' | ' |
Other (income) expense, net | -473 | 0 | ' | ' |
Operating income | -14,196 | -12,802 | ' | ' |
Intercompany items | 17,278 | 31,120 | ' | ' |
Interest (expense) income, net | -16,045 | -22,570 | ' | ' |
Income from continuing operations before income taxes | -12,963 | -4,252 | ' | ' |
Provision for income taxes | -5,054 | -9,276 | ' | ' |
Equity in income of subsidiaries | 56,770 | 137,115 | ' | ' |
Income from continuing operations | 48,861 | 142,139 | ' | ' |
Comprehensive income | 2,403 | 145,367 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 29,665 | 26,993 | ' | ' |
Accounts receivable, net | 0 | ' | 0 | ' |
Inventories | 0 | ' | 0 | ' |
Other current assets | 72,409 | ' | 68,792 | ' |
Total current assets | 102,074 | ' | 191,693 | ' |
Property, plant and equipment, net | 20,885 | ' | 18,081 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 0 | ' | 0 | ' |
Goodwill | 0 | ' | 0 | ' |
Deferred income taxes | -33,294 | ' | -49,393 | ' |
Other non-current assets | 4,113,404 | ' | 4,168,916 | ' |
Total other assets | 4,080,110 | ' | 4,119,523 | ' |
Total assets | 4,203,069 | ' | 4,329,297 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 50,000 | ' | 50,000 | ' |
Trade accounts payable | 731 | ' | 2,565 | ' |
Employee compensation and benefits | 8,497 | ' | 10,080 | ' |
Advance payments and progress billings | 0 | ' | 0 | ' |
Accrued warranties | 0 | ' | 0 | ' |
Other accrued liabilities | 38,454 | ' | 24,545 | ' |
Current liabilities of discontinued operations | 0 | ' | 0 | ' |
Total current liabilities | 97,682 | ' | 87,190 | ' |
Long-term obligations | 1,243,860 | ' | 1,256,164 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 19,471 | ' | 19,881 | ' |
Accrued pension costs | 131,673 | ' | 136,886 | ' |
Other non-current liabilities | -14,656 | ' | -29,193 | ' |
Total other liabilities | 136,488 | ' | 127,574 | ' |
Shareholders’ equity | 2,725,039 | ' | 2,858,369 | ' |
Total liabilities and shareholders’ equity | 4,203,069 | ' | 4,329,297 | ' |
Operating Activities: | ' | ' | ' | ' |
Net cash provided (used) by operating activities of continuing operations | 61,014 | 51,491 | ' | ' |
Net cash provided (used) by operating activities of discontinued operations | 0 | 0 | ' | ' |
Net cash provided by operating activities | 61,014 | 51,491 | ' | ' |
Investing Activities: | ' | ' | ' | ' |
Property, plant and equipment acquired | -3,544 | -1,417 | ' | ' |
Proceeds from sale of property, plant and equipment | 0 | 0 | ' | ' |
Other investing activities, net | -21 | -32 | ' | ' |
Net cash used by investing activities | -3,565 | -1,449 | ' | ' |
Financing Activities: | ' | ' | ' | ' |
Common stock issued | 1,985 | 3,012 | ' | ' |
Excess tax (detriment) benefit from share-based compensation awards | -284 | 1,522 | ' | ' |
Dividends paid | -17,850 | -18,542 | ' | ' |
Repayments of term loan | -12,500 | -12,500 | ' | ' |
Change in short and other long-term obligations, net | 0 | 0 | ' | ' |
Treasury stock purchased | -122,036 | ' | ' | ' |
Net cash used by financing activities | -150,685 | -26,508 | ' | ' |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 0 | ' | ' |
(Decrease) Increase in Cash and Cash Equivalents | -93,236 | 23,534 | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 122,901 | 3,459 | ' | ' |
Cash and Cash Equivalents at End of Period | 29,665 | 26,993 | ' | ' |
Subsidiary Guarantors | ' | ' | ' | ' |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | 478,576 | 600,956 | ' | ' |
Cost of sales | 361,369 | 410,643 | ' | ' |
Product development, selling and administrative expenses | 67,591 | 74,117 | ' | ' |
Other (income) expense, net | 2,330 | 9,176 | ' | ' |
Operating income | 47,286 | 107,020 | ' | ' |
Intercompany items | -19,986 | -19,848 | ' | ' |
Interest (expense) income, net | 1,854 | 97 | ' | ' |
Income from continuing operations before income taxes | 29,154 | 87,269 | ' | ' |
Provision for income taxes | 27,256 | 57,046 | ' | ' |
Equity in income of subsidiaries | 33,013 | 92,701 | ' | ' |
Income from continuing operations | 34,911 | 122,924 | ' | ' |
Comprehensive income | 33,376 | 121,201 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 6,580 | 3,584 | ' | ' |
Accounts receivable, net | 390,404 | ' | 402,321 | ' |
Inventories | 455,890 | ' | 456,345 | ' |
Other current assets | 8,799 | ' | 16,957 | ' |
Total current assets | 861,673 | ' | 895,984 | ' |
Property, plant and equipment, net | 363,273 | ' | 373,235 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 242,456 | ' | 247,200 | ' |
Goodwill | 454,199 | ' | 454,199 | ' |
Deferred income taxes | 0 | ' | 0 | ' |
Other non-current assets | 1,800,826 | ' | 2,070,239 | ' |
Total other assets | 2,497,481 | ' | 2,771,638 | ' |
Total assets | 3,722,427 | ' | 4,040,857 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 0 | ' | 449 | ' |
Trade accounts payable | 138,347 | ' | 165,045 | ' |
Employee compensation and benefits | 42,910 | ' | 52,260 | ' |
Advance payments and progress billings | 162,715 | ' | 144,853 | ' |
Accrued warranties | 27,281 | ' | 30,111 | ' |
Other accrued liabilities | 49,851 | ' | 54,285 | ' |
Current liabilities of discontinued operations | 11,684 | ' | 11,684 | ' |
Total current liabilities | 432,788 | ' | 458,687 | ' |
Long-term obligations | 0 | ' | 763 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 848 | ' | 842 | ' |
Accrued pension costs | 5,502 | ' | 5,685 | ' |
Other non-current liabilities | 8,169 | ' | 7,851 | ' |
Total other liabilities | 14,519 | ' | 14,378 | ' |
Shareholders’ equity | 3,275,120 | ' | 3,567,029 | ' |
Total liabilities and shareholders’ equity | 3,722,427 | ' | 4,040,857 | ' |
Operating Activities: | ' | ' | ' | ' |
Net cash provided (used) by operating activities of continuing operations | -9,829 | 15,201 | ' | ' |
Net cash provided (used) by operating activities of discontinued operations | 67 | -1,571 | ' | ' |
Net cash provided by operating activities | -9,762 | 13,630 | ' | ' |
Investing Activities: | ' | ' | ' | ' |
Property, plant and equipment acquired | -4,084 | -14,081 | ' | ' |
Proceeds from sale of property, plant and equipment | 1,277 | -2,489 | ' | ' |
Other investing activities, net | 0 | 0 | ' | ' |
Net cash used by investing activities | -2,807 | -16,570 | ' | ' |
Financing Activities: | ' | ' | ' | ' |
Common stock issued | 0 | 0 | ' | ' |
Excess tax (detriment) benefit from share-based compensation awards | 0 | 0 | ' | ' |
Dividends paid | 0 | 0 | ' | ' |
Repayments of term loan | 0 | 0 | ' | ' |
Change in short and other long-term obligations, net | -1,212 | -104 | ' | ' |
Treasury stock purchased | 0 | ' | ' | ' |
Net cash used by financing activities | -1,212 | -104 | ' | ' |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 0 | ' | ' |
(Decrease) Increase in Cash and Cash Equivalents | -13,781 | -3,044 | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 20,361 | 6,628 | ' | ' |
Cash and Cash Equivalents at End of Period | 6,580 | 3,584 | ' | ' |
Non-Guarantor Subsidiaries | ' | ' | ' | ' |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | 604,861 | 877,521 | ' | ' |
Cost of sales | 447,537 | 621,120 | ' | ' |
Product development, selling and administrative expenses | 70,769 | 70,362 | ' | ' |
Other (income) expense, net | -4,997 | -10,881 | ' | ' |
Operating income | 91,552 | 196,920 | ' | ' |
Intercompany items | -9,071 | -35,657 | ' | ' |
Interest (expense) income, net | 371 | 7,320 | ' | ' |
Income from continuing operations before income taxes | 82,852 | 168,583 | ' | ' |
Provision for income taxes | 362 | 16,090 | ' | ' |
Equity in income of subsidiaries | 0 | 0 | ' | ' |
Income from continuing operations | 82,490 | 152,493 | ' | ' |
Comprehensive income | 34,786 | 149,000 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 254,654 | 239,318 | ' | ' |
Accounts receivable, net | 571,903 | ' | 687,790 | ' |
Inventories | 804,206 | ' | 813,182 | ' |
Other current assets | 126,808 | ' | 107,564 | ' |
Total current assets | 1,757,571 | ' | 1,870,983 | ' |
Property, plant and equipment, net | 513,726 | ' | 521,326 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 83,116 | ' | 84,612 | ' |
Goodwill | 1,025,122 | ' | 1,026,320 | ' |
Deferred income taxes | 71,017 | ' | 90,925 | ' |
Other non-current assets | 2,617,174 | ' | 3,963,205 | ' |
Total other assets | 3,796,429 | ' | 5,165,062 | ' |
Total assets | 6,067,726 | ' | 7,557,371 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 8,356 | ' | 8,220 | ' |
Trade accounts payable | 144,891 | ' | 220,509 | ' |
Employee compensation and benefits | 44,359 | ' | 68,215 | ' |
Advance payments and progress billings | 331,384 | ' | 269,628 | ' |
Accrued warranties | 50,523 | ' | 55,621 | ' |
Other accrued liabilities | 158,414 | ' | 211,074 | ' |
Current liabilities of discontinued operations | 0 | ' | 0 | ' |
Total current liabilities | 737,927 | ' | 833,267 | ' |
Long-term obligations | 14 | ' | 0 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 0 | ' | 0 | ' |
Accrued pension costs | 7,146 | ' | 7,234 | ' |
Other non-current liabilities | 153,097 | ' | 164,510 | ' |
Total other liabilities | 160,243 | ' | 171,744 | ' |
Shareholders’ equity | 5,169,542 | ' | 6,552,360 | ' |
Total liabilities and shareholders’ equity | 6,067,726 | ' | 7,557,371 | ' |
Operating Activities: | ' | ' | ' | ' |
Net cash provided (used) by operating activities of continuing operations | 13,654 | 25,373 | ' | ' |
Net cash provided (used) by operating activities of discontinued operations | 0 | 0 | ' | ' |
Net cash provided by operating activities | 13,654 | 25,373 | ' | ' |
Investing Activities: | ' | ' | ' | ' |
Property, plant and equipment acquired | -19,027 | -39,090 | ' | ' |
Proceeds from sale of property, plant and equipment | 804 | 3,542 | ' | ' |
Other investing activities, net | 0 | 1,825 | ' | ' |
Net cash used by investing activities | -18,223 | -33,723 | ' | ' |
Financing Activities: | ' | ' | ' | ' |
Common stock issued | 0 | 0 | ' | ' |
Excess tax (detriment) benefit from share-based compensation awards | 0 | 0 | ' | ' |
Dividends paid | 0 | 0 | ' | ' |
Repayments of term loan | 0 | 0 | ' | ' |
Change in short and other long-term obligations, net | -47 | -4,598 | ' | ' |
Treasury stock purchased | 0 | ' | ' | ' |
Net cash used by financing activities | -47 | -4,598 | ' | ' |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -3,177 | -1,520 | ' | ' |
(Decrease) Increase in Cash and Cash Equivalents | -7,793 | -14,468 | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 262,447 | 253,786 | ' | ' |
Cash and Cash Equivalents at End of Period | 254,654 | 239,318 | ' | ' |
Eliminations | ' | ' | ' | ' |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | -244,125 | -328,600 | ' | ' |
Cost of sales | -204,728 | -258,614 | ' | ' |
Product development, selling and administrative expenses | 0 | 0 | ' | ' |
Other (income) expense, net | 0 | 0 | ' | ' |
Operating income | -39,397 | -69,986 | ' | ' |
Intercompany items | 11,779 | 24,385 | ' | ' |
Interest (expense) income, net | 0 | 0 | ' | ' |
Income from continuing operations before income taxes | -27,618 | -45,601 | ' | ' |
Provision for income taxes | 0 | 0 | ' | ' |
Equity in income of subsidiaries | -89,783 | -229,816 | ' | ' |
Income from continuing operations | -117,401 | -275,417 | ' | ' |
Comprehensive income | -68,162 | -270,201 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 0 | ' | ' | ' |
Accounts receivable, net | -8,515 | ' | -6,448 | ' |
Inventories | -124,984 | ' | -129,783 | ' |
Other current assets | 15 | ' | 15 | ' |
Total current assets | -133,484 | ' | -136,216 | ' |
Property, plant and equipment, net | 0 | ' | 0 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 0 | ' | 0 | ' |
Goodwill | 0 | ' | 0 | ' |
Deferred income taxes | 0 | ' | 0 | ' |
Other non-current assets | -8,336,062 | ' | -10,001,727 | ' |
Total other assets | -8,336,062 | ' | -10,001,727 | ' |
Total assets | -8,469,546 | ' | -10,137,943 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 0 | ' | 0 | ' |
Trade accounts payable | 0 | ' | 0 | ' |
Employee compensation and benefits | 0 | ' | 0 | ' |
Advance payments and progress billings | -21,253 | ' | -14,713 | ' |
Accrued warranties | 0 | ' | 0 | ' |
Other accrued liabilities | -3,631 | ' | -3,841 | ' |
Current liabilities of discontinued operations | 0 | ' | 0 | ' |
Total current liabilities | -24,884 | ' | -18,554 | ' |
Long-term obligations | 0 | ' | 0 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 0 | ' | 0 | ' |
Accrued pension costs | 0 | ' | 0 | ' |
Other non-current liabilities | 0 | ' | 0 | ' |
Total other liabilities | 0 | ' | 0 | ' |
Shareholders’ equity | -8,444,662 | ' | -10,119,389 | ' |
Total liabilities and shareholders’ equity | -8,469,546 | ' | -10,137,943 | ' |
Financing Activities: | ' | ' | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 0 | ' | ' | ' |
Cash and Cash Equivalents at End of Period | 0 | ' | ' | ' |
Consolidated | ' | ' | ' | ' |
Condensed Consolidating Statement of Income | ' | ' | ' | ' |
Net sales | 839,312 | 1,149,877 | ' | ' |
Cost of sales | 604,178 | 773,149 | ' | ' |
Product development, selling and administrative expenses | 153,029 | 157,281 | ' | ' |
Other (income) expense, net | -3,140 | -1,705 | ' | ' |
Operating income | 85,245 | 221,152 | ' | ' |
Intercompany items | 0 | 0 | ' | ' |
Interest (expense) income, net | -13,820 | -15,153 | ' | ' |
Income from continuing operations before income taxes | 71,425 | 205,999 | ' | ' |
Provision for income taxes | 22,564 | 63,860 | ' | ' |
Equity in income of subsidiaries | 0 | 0 | ' | ' |
Income from continuing operations | 48,861 | 142,139 | ' | ' |
Comprehensive income | 2,403 | 145,367 | ' | ' |
Current assets: | ' | ' | ' | ' |
Cash and cash equivalents | 290,899 | 269,895 | ' | ' |
Accounts receivable, net | 953,792 | ' | 1,083,663 | ' |
Inventories | 1,135,112 | ' | 1,139,744 | ' |
Other current assets | 208,031 | ' | 193,328 | ' |
Total current assets | 2,587,834 | ' | 2,822,444 | ' |
Property, plant and equipment, net | 897,884 | ' | 912,642 | ' |
Other assets: | ' | ' | ' | ' |
Other intangible assets, net | 325,572 | ' | 331,812 | ' |
Goodwill | 1,479,321 | ' | 1,480,519 | ' |
Deferred income taxes | 37,723 | ' | 41,532 | ' |
Other non-current assets | 195,342 | ' | 200,633 | ' |
Total other assets | 2,037,958 | ' | 2,054,496 | ' |
Total assets | 5,523,676 | ' | 5,789,582 | ' |
Current liabilities: | ' | ' | ' | ' |
Short-term notes payable, including current portion of long-term obligations | 58,356 | ' | 58,669 | ' |
Trade accounts payable | 283,969 | ' | 388,119 | ' |
Employee compensation and benefits | 95,766 | ' | 130,555 | ' |
Advance payments and progress billings | 472,846 | ' | 399,768 | ' |
Accrued warranties | 77,804 | ' | 85,732 | ' |
Other accrued liabilities | 243,088 | ' | 286,063 | ' |
Current liabilities of discontinued operations | 11,684 | ' | 11,684 | ' |
Total current liabilities | 1,243,513 | ' | 1,360,590 | ' |
Long-term obligations | 1,243,874 | ' | 1,256,927 | ' |
Other liabilities: | ' | ' | ' | ' |
Liabilities for postretirement benefits | 20,319 | ' | 20,723 | ' |
Accrued pension costs | 144,321 | ' | 149,805 | ' |
Other non-current liabilities | 146,610 | ' | 143,168 | ' |
Total other liabilities | 311,250 | ' | 313,696 | ' |
Shareholders’ equity | 2,725,039 | ' | 2,858,369 | ' |
Total liabilities and shareholders’ equity | 5,523,676 | ' | 5,789,582 | ' |
Operating Activities: | ' | ' | ' | ' |
Net cash provided (used) by operating activities of continuing operations | 64,839 | 92,065 | ' | ' |
Net cash provided (used) by operating activities of discontinued operations | 67 | -1,571 | ' | ' |
Net cash provided by operating activities | 64,906 | 90,494 | ' | ' |
Investing Activities: | ' | ' | ' | ' |
Property, plant and equipment acquired | -26,655 | -54,588 | ' | ' |
Proceeds from sale of property, plant and equipment | 2,081 | 1,053 | ' | ' |
Other investing activities, net | -21 | 1,793 | ' | ' |
Net cash used by investing activities | -24,595 | -51,742 | ' | ' |
Financing Activities: | ' | ' | ' | ' |
Common stock issued | 1,985 | 3,012 | ' | ' |
Excess tax (detriment) benefit from share-based compensation awards | -284 | 1,522 | ' | ' |
Dividends paid | -17,850 | -18,542 | ' | ' |
Repayments of term loan | -12,500 | -12,500 | ' | ' |
Change in short and other long-term obligations, net | -1,259 | -4,702 | ' | ' |
Treasury stock purchased | -122,036 | ' | ' | ' |
Net cash used by financing activities | -151,944 | -31,210 | ' | ' |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -3,177 | -1,520 | ' | ' |
(Decrease) Increase in Cash and Cash Equivalents | -114,810 | 6,022 | ' | ' |
Cash and Cash Equivalents at Beginning of Period | 405,709 | 263,873 | ' | ' |
Cash and Cash Equivalents at End of Period | $290,899 | $269,895 | ' | ' |